Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine and Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute, Seoul, Republic of Korea.
Lab Anim. 2014 Apr;48(2):124-31. doi: 10.1177/0023677213512821. Epub 2013 Nov 20.
Investigation of molecular mechanisms and the efficiency of novel therapeutics for the treatment and prevention of a disease require accurate and accessible preclinical models. Recent developments in personalized medicine employing molecular medicine concepts have favored mice because their genetic make-up is well known and easy to manipulate. For lung cancer, however, orthotopic models in mice are difficult to create due to their narrow glottis openings which act as obstacles to intubation. In the present study, we develop an orotracheal intubation device which gives a clearer view of the narrow mouse glottis and increases the success rate of intubation. We achieved anesthetization via orotracheal intubation using this novel device and then performed a thoracotomy by making an incision between the fourth and fifth intercostal ribs on the right side of the chest. Lung tumor cells were then inoculated at this site. Tumor formation was monitored through bioluminescence optical and magnetic resonance (MR) imagings, which was confirmed by histological analysis. Temperature drop (<35) and/or loss of body weight (>30% of the initial body weight) observed during any procedure were used as interruption criteria. This method exhibited high tumorigenicity (100%) and a low mortality rate (8%) at specific sites making it ideal for creating orthotopic lung tumor models and making it particularly useful for sequential follow-up studies using in vivo image analysis.
研究疾病治疗和预防的分子机制和新型治疗方法的效率需要准确且易于获取的临床前模型。采用分子医学概念的个性化医学的最新发展有利于使用小鼠,因为它们的基因组成是众所周知的,并且易于操作。然而,对于肺癌,由于其狭窄的声门开口会阻碍插管,因此在小鼠中建立原位模型很困难。在本研究中,我们开发了一种经口气管插管装置,该装置可更清楚地观察狭窄的小鼠声门,并提高插管成功率。我们通过使用这种新型装置经口气管插管实现麻醉,然后在胸部右侧第四和第五肋之间做一个切口进行开胸手术。然后在此部位接种肺肿瘤细胞。通过生物发光光学和磁共振成像(MR)监测肿瘤形成,并通过组织学分析进行确认。在任何过程中观察到的体温下降(<35)和/或体重减轻(初始体重的>30%)被用作中断标准。这种方法在特定部位具有很高的致瘤性(100%)和低死亡率(8%),非常适合建立原位肺肿瘤模型,特别适合使用活体图像分析进行后续的随访研究。